“Gainsharing” methods of payment can boost use of biosimilars, a less expensive cancer treatment A new study looks at mechanisms that could induce hospitals to switch to less expensive biosimilar treatment alternatives.

New research led by Professor of #HealthEconomics James Robinson highlights how #gainsharing can significantly boost the use of #biosimilars, encouraging providers to choose cost-effective treatments, lowering #healthcare expenses while maintaining high-quality care. https://ow.ly/9Yf450YvCHt